High-throughput screening assays for novel antibacterial identification: current advances and future prospects

Area of Science:

• Microbiology
• Drug Discovery
• Medicinal Chemistry

Background:

• High-throughput screening (HTS) is crucial for identifying antibacterial compounds.
• Advances have made HTS accessible to smaller research groups.
• The current antibacterial pipeline is insufficient to combat rising antibiotic resistance.

Purpose of the Study:

• To review HTS applications in antibacterial drug discovery.
• To outline standard techniques and their limitations.
• To highlight novel methods that better simulate infection environments.

Main Methods:

• Literature review of PubMed and Google Scholar.
• Focus on antibacterial HTS methodologies from the last 15 years, including seminal works.
• Analysis of standard growth inhibition assays and emerging in vitro/in vivo methods.

Main Results:

• Traditional HTS assays use conditions that do not accurately reflect disease environments.
• This discrepancy limits the translational success of identified drug candidates.
• Emerging methods aim to bridge this gap by simulating infection conditions more effectively.

Conclusions:

• Standard HTS methods require refinement to improve the success of antibacterial drug discovery.
• Novel screening approaches are essential for developing effective treatments against antibiotic resistance.
• Future research should focus on developing and validating HTS methods that mimic in vivo infection settings.